Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,856.00 GBX | -0.94% | -4.43% | +11.85% |
06:13pm | European Equities Close Lower in Wednesday Trading; EU, Euro Area Inflation Declines in August | MT |
01:43pm | AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment | MT |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
183.54 | +16.47% | 20 | |||||||
995.42 | +9.85% | 25 | |||||||
967.54 | +7.10% | 26 | |||||||
171.32 | +2.55% | 22 | |||||||
196.30 | +1.47% | 27 | |||||||
139.03 | +17.53% | 26 | |||||||
301.11 | +13.11% | 19 | |||||||
116.54 | +0.67% | 20 | |||||||
324.71 | -2.43% | 24 | |||||||
33.23 | +11.41% | 22 | |||||||
112.40 | +9.23% | 22 | |||||||
83.54 | +0.59% | 27 | |||||||
53.34 | +7.78% | 21 | |||||||
19.68 | +22.27% | 21 | |||||||
6,663.33 | -2.97% | 15 | |||||||
6,512.50 | +31.09% | 16 | |||||||
3.865 | -2.64% | 17 | |||||||
4,768.83 | +13.30% | 18 | |||||||
58.20 | +29.99% | 15 | |||||||
Average | 1,142.34 | +9.81% | 21 | ||||||
Weighted average by Cap. | 706.53 | +8.39% | 23 |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector consensus
MarketScreener is also available in this country: United States.
Switch edition